D L Carlson Investment Group Inc. Buys Shares of 9,444 Danaher Corporation $DHR

D L Carlson Investment Group Inc. purchased a new stake in shares of Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 9,444 shares of the conglomerate’s stock, valued at approximately $6,800,000. Danaher accounts for approximately 1.1% of D L Carlson Investment Group Inc.’s portfolio, making the stock its 23rd biggest holding.

Other institutional investors have also modified their holdings of the company. Portfolio Design Labs LLC acquired a new stake in shares of Danaher in the 2nd quarter worth about $992,000. Reliant Investment Partners LLC acquired a new position in Danaher during the 2nd quarter valued at about $369,000. Ninepoint Partners LP bought a new position in Danaher in the 2nd quarter worth about $1,542,000. Advisors Capital Management LLC bought a new position in Danaher in the 2nd quarter worth about $1,877,000. Finally, MJP Associates Inc. ADV acquired a new stake in shares of Danaher in the second quarter valued at approximately $302,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 2.2%

DHR opened at $216.14 on Friday. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The stock’s fifty day moving average is $195.01 and its 200-day moving average is $192.43. The company has a market capitalization of $151.94 billion, a PE ratio of 38.39, a P/E/G ratio of 2.63 and a beta of 0.78.

Danaher (NYSE:DHR) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company’s quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter last year, the business posted $0.77 earnings per share. On average, equities analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on DHR shares. Argus cut their price target on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a report on Friday, April 24th. Piper Sandler initiated coverage on Danaher in a research report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price on the stock. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $240.00 target price on shares of Danaher in a research note on Wednesday, July 22nd. Wall Street Zen lowered Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Finally, Stifel Nicolaus decreased their price target on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.